# clm_ECF62E043F01

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_net_income  
value: -176,096,000 United States dollar  
valid_from: 2011-03-31  
valid_to: 2011-06-30  
published: 2012-05-10  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_46C52FB158CE  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly net income: -176,096,000 United States dollar", as of 2011-03-31 (until 2011-06-30). Claim clm_ECF62E043F01, https://asof.is/claim/clm_ECF62E043F01, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000104746912005755/0001047469-12-005755-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q1 FY2012, filed 2012-05-10  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000104746912005755/0001047469-12-005755-index.htm (primary, SEC EDGAR 10-Q Q1 FY2012, published 2012-05-10)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_net_income | -208,957,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_ECF62E043F01](/claim/clm_ECF62E043F01.md) | [clm_185D3E640F90](/claim/clm_185D3E640F90.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.